摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Boc-Lys-OMe acetate | 136832-75-2

中文名称
——
中文别名
——
英文名称
Boc-Lys-OMe acetate
英文别名
Boc-Lys-OMe acetate salt;acetic acid;methyl (2S)-6-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoate
Boc-Lys-OMe acetate化学式
CAS
136832-75-2
化学式
C2H4O2*C12H24N2O4
mdl
——
分子量
320.386
InChiKey
IQQHZKIYBAMWEX-FVGYRXGTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.27
  • 重原子数:
    22
  • 可旋转键数:
    9
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.79
  • 拓扑面积:
    128
  • 氢给体数:
    3
  • 氢受体数:
    7

反应信息

  • 作为反应物:
    描述:
    Boc-Lys-OMe acetatesodium hydroxide三乙胺 作用下, 以 甲醇氯仿 为溶剂, 反应 17.25h, 生成 Boc-Lys(Trt)-OH
    参考文献:
    名称:
    Probing the functional conformation of neuropeptide Y through the design and study of cyclic analogs
    摘要:
    The functional importance of the PP-fold conformation in neuropeptide Y (NPY) was investigated. NPY and N(alpha)-Ac-NPY(10-36), and corresponding cyclic analogues cyclo18,22-[Lys18,Asp22]-NPY and N(alpha)-Ac-cyclo18,22-[Lys18,Asp22]-NPY(10-36), were synthesized. Strategies for synthesis of the cyclic analogues included the use of the Kaiser oxime resin and a segment condensation approach. Circular dichroism studies in phosphate buffer, pH 5.0, indicated self-association of all four peptides at low micromolar concentrations. Monomeric N(alpha)-Ac-NPY(10-36) showed only 13% alpha-helix, compared to 32% alpha-helix for monomeric NPY, demonstrating a helix-stabilizing effect of residues 1-9 that is consistent with the PP fold. The [Lys18,Lys22] lactam bridge stabilized the helical conformation in N(alpha)-Ac-NPY(10-36) (51% alpha-helix), but was helix destabilizing in NPY (21% alpha-helix). In rat brain receptor binding assays, the cyclic and linear N(alpha)-Ac-NPY(10-36) analogues were equipotent (IC50 = 13 nM for I-125-BH-NPY displacement), although the cyclic analogue was twice as potent in rat vas deferens assays. NPY was more potent than its cyclic analogue in the brain receptor binding assays (IC50 = 0.07 and 0.25 nM, respectively), but these peptides were equipotent in the vas deferens assays. These results support a functional role for the PP fold in NPY and correlate with the solution conformations of the monomeric peptides.
    DOI:
    10.1021/jm00084a021
  • 作为产物:
    描述:
    N6-((苄氧基)羰基)-N2-(叔丁氧基羰基)-L-赖氨酸甲酯溶剂黄146 在 palladium on activated charcoal 氢气 作用下, 以 甲醇 为溶剂, 反应 0.75h, 生成 Boc-Lys-OMe acetate
    参考文献:
    名称:
    Synthesis of hypusine and other polyamines using dibenzyltriazones for amino protection
    摘要:
    The use of 1,3-dibenzyl-5-substituted-hexahydro-2-oxo-1,3,5-triazine ("dibenzyltriazone") as a protecting group for primary amino is described. Optimized conditions for formation and hydrolysis of dibenzyltriazones, as well as a variety of transformations (reduction, oxidation, hydroxyl modification, C-C bond formation) compatible with this protecting group, are presented. N-Protected amino aldehydes such as 46, 47, and 94 are particularly valuable building blocks, as demonstrated by the syntheses of hypusine (86), deoxyhypusine (85), spermidine (74), and two unsaturated spermidine analogues 81 and 84.
    DOI:
    10.1021/jo00049a036
点击查看最新优质反应信息

文献信息

  • Immunoproteasome Inhibitor–Doxorubicin Conjugates Target Multiple Myeloma Cells and Release Doxorubicin upon Low-Dose Photon Irradiation
    作者:Elmer Maurits、Michel J. van de Graaff、Santina Maiorana、Dennis P. A. Wander、Patrick M. Dekker、Sabina Y. van der Zanden、Bogdan I. Florea、Jacques J. C. Neefjes、Herman S. Overkleeft、Sander I. van Kasteren
    DOI:10.1021/jacs.9b11969
    日期:2020.4.22
    are anthracyclines such as doxorubicin. We here present a new drug targeting approach that combines both drug classes into a single molecule. Doxorubicin was conjugated to an immunoproteasome-selective inhibitor via light-cleavable linkers, yielding peptide epoxyketone–doxorubicin prodrugs that remained selective and active toward immunoproteasomes. Upon cellular uptake and immunoproteasome inhibition
    蛋白酶体抑制剂是治疗血液系统癌症的公认治疗剂,蒽环类药物如阿霉素也是如此。我们在这里提出了一种新的药物靶向方法,它将两种药物类别结合到一个分子中。多柔比星通过光可裂解接头与免疫蛋白酶体选择性抑制剂偶联,产生肽环氧基酮-多柔比星前药,该前药对免疫蛋白酶体保持选择性和活性。在细胞摄取和免疫蛋白酶体抑制后,多柔比星通过光照射从免疫蛋白酶体抑制剂中释放出来。多发性骨髓瘤细胞以这种方式受到双重打击:免疫蛋白酶体抑制和阿霉素诱导的毒性。我们的策略需要靶向细胞毒剂,
  • [EN] BIOSYNTHETICALLY GENERATED PYRROLINE-CARBOXY-LYSINE AND SITE SPECIFIC PROTEIN MODIFICATIONS VIA CHEMICAL DERIVATIZATION OF PYRROLINE-CARBOXY-LYSINE AND PYRROLYSINE RESIDUES<br/>[FR] PYRROLINE-CARBOXY-LYSINE PRODUITE PAR BIOSYNTHÈSE ET MODIFICATIONS DE PROTÉINES SPÉCIFIQUES DE SITE OBTENUES PAR UNE DÉRIVATISATION CHIMIQUE DE PYRROLINE-CARBOXY-LYSINE ET DE RÉSIDUS DE PYRROLYSINE
    申请人:IRM LLC
    公开号:WO2010048582A1
    公开(公告)日:2010-04-29
    Disclosed herein is pyrroline-carboxy-lysine (PCL), a pyrrolysine analogue, which is a natural, biosynthetically generated amino acid, and methods for biosynthetically generating PCL. Also disclosed herein are proteins, polypeptides and peptides that have PCL incorporated therein and methods for incorporating PCL into such proteins, polypeptides and peptides. Also disclosed herein is the site-specific derivatization of proteins, polypeptides and peptides having PCL or pyrrolysine incorporated therein. Also disclosed herein is the crosslinking of proteins, polypeptides and peptides having PCL or pyrrolysine incorporated therein.
    本文披露了吡咯酮羧基赖氨酸(PCL),一种吡咯赖氨酸类似物,它是一种天然的、生物合成产生的氨基酸,以及生物合成生成PCL的方法。本文还披露了含有PCL的蛋白质、多肽和肽以及将PCL纳入这些蛋白质、多肽和肽中的方法。本文还披露了具有PCL或吡咯赖氨酸的蛋白质、多肽和肽的特定位点衍生化。本文还披露了具有PCL或吡咯赖氨酸的蛋白质、多肽和肽的交联。
  • Hydrogen Atom Transfer-Driven Enantioselective Minisci Reaction of Amides
    作者:Rupert S. J. Proctor、Padon Chuentragool、Avene C. Colgan、Robert J. Phipps
    DOI:10.1021/jacs.1c01556
    日期:2021.4.7
    formed stereocenter as well as site selectivity on both the heteroarene and the amide. This is achieved by the use of a chiral phosphoric acid catalyst in conjunction with diacetyl as a combined hydrogen atom transfer reagent and oxidant. Diacetyl is directly photoexcitable, and thus, no extraneous photocatalyst is required: an added feature that contributes to the simplicity and practicality of the
    Minisci型反应是围绕基本杂芳烃构建复杂性的最强大方法之一。最理想的变体涉及每个伙伴上 C-H 键的正式氧化偶联,从而得到最简单的起始材料。我们在此公开了一种方法,该方法能够实现线性酰胺和杂芳烃的这种偶联,并完全控制新形成的立构中心处的对映选择性以及杂芳烃和酰胺两者上的位点选择性。这是通过使用手性磷酸催化剂与联乙酰作为组合的氢原子转移试剂和氧化剂来实现的。二乙酰可直接光激发,因此不需要额外的光催化剂:这一附加功能有助于该方案的简单性和实用性。
  • A DNA-Encoded Library of Chemical Compounds Based on Common Scaffolding Structures Reveals the Impact of Ligand Geometry on Protein Recognition
    作者:Nicholas Favalli、Stefan Biendl、Marco Hartmann、Jacopo Piazzi、Filippo Sladojevich、Susanne Gräslund、Peter J. Brown、Katja Näreoja、Herwig Schüler、Jörg Scheuermann、Raphael Franzini、Dario Neri
    DOI:10.1002/cmdc.201800193
    日期:2018.7.6
    A DNAencoded chemical library (DECL) with 1.2 million compounds was synthesized by combinatorial reaction of seven central scaffolds with two sets of 343×492 building blocks. Library screening by affinity capture revealed that for some target proteins, the chemical nature of building blocks dominated the selection results, whereas for other proteins, the central scaffold also crucially contributed
    通过七个中央支架与两组 343×492 构建块的组合反应,合成了一个包含 120 万种化合物的 DNA 编码化学文库 (DECL)。通过亲和力捕获进行的文库筛选表明,对于某些靶蛋白,构建块的化学性质主导了选择结果,而对于其他蛋白质,中心支架也对配体亲和力至关重要。发现基于 3,5-双(氨基甲基)苯甲酸核心结构的分子与人血清白蛋白结合的K d值为 6 nm ,而在等距但灵活的 L-赖氨酸支架上具有相同取代基的化合物显示140 - 降低亲和力。18 nm tankyrase-1 粘合剂具有特色l赖氨酸作为连接部分,而基于d-赖氨酸或 (2 S ,4 S )-氨基- l-脯氨酸的分子与靶标没有可检测到的结合。这项工作表明,使化学结构单元朝向蛋白质靶标的方向易于定位的中央支架可以提高编码文库的筛选效率。
  • Synthesis of the reported structure of the naturally occurring siderophore nocardimicin B
    作者:James C. Banks、Christopher J. Moody
    DOI:10.1016/j.tetlet.2009.02.124
    日期:2009.7
    A total synthesis of the reported structure of the naturally occurring siderophore nocardimicin B is reported: the synthetic material appears to be diastereomeric with the natural product.
    据报道,天然存在的铁载体诺卡霉素B的结构已完全合成:合成材料似乎与天然产物是非对映异构的。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物